Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.730
-0.040 (-2.26%)
At close: Jan 17, 2025, 4:00 PM
1.770
+0.040 (2.31%)
After-hours: Jan 17, 2025, 7:53 PM EST
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $22.22 million as of January 17, 2025.
Market Cap
22.22M
Enterprise Value
19.15M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $22.22M, a decrease of -33.44%. That is a compound annual growth rate of -70.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 22.22M | 13.82% |
| Dec 31, 2024 | 19.53M | -41.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |